GL1X · GenesisL1 explorer

Research workbench

Neutron diffraction structure of endothiapepsin in complex with a gem- diol inhibitor.

Analyse Neutron diffraction structure of endothiapepsin in complex with a gem- diol… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2VS2
Type
protein
Length
328 residues
Chains
1
Method
neutron diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Endothiapepsin
EC
3.4.23.22
UniProt
P11838
Ligands
SUI, 0QS
Pockets
1 · best druggability 0.58

Structure

neutron diffraction · 1 distinct chain · 11% helix, 46% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEndothiapepsin (EC 3.4.23.22)protein32811% helix, 46% strandP11838

Ligands and binding sites

  • SUI · (3-amino-2,5-dioxo-1-pyrrolidinyl)acetic acid · ligand · chains A
  • 0QS · N~2~-[(2R)-2-benzyl-3-(tert-butylsulfonyl)propanoyl]-N-{(1R)-1-(cyclohexylmethyl)-3,3-difluoro-2,2-dihydroxy-4-[(2-morpholin-4-ylethyl)amino]-4-oxobutyl}-3-(1H-imidazol-3-ium-4-yl)-L-alaninamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13070.580.77350QS

Modifications

Observed in the structure: 2 covalent, 1 disulfide (covalent ligand, disulfide).

Compared structures

  • 2VS2 · Neutron diffraction structure of endothiapepsin in complex with a gem- diol inhibitor. · the same entry in another collection · chain A against A, TM-score 1.00
  • P11838 · AlphaFold monomer V2.0 prediction for endothiapepsin (P11838) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.